Media Thread, page-12662

First 12662 Last

Share
Profile

Follow
Kombumerri

377 Posts.

52

24/03/24

21:17

Post #: 73034740
Share

Originally posted by Outlander2: ↑

Hi Hawkbar,

I'm not convinced that it was a case of Dr Glover being ... "thrown in at the deep end" ... he his an accomplished scientist
in his own right. I thing you will find that he is 'across' most trials that IMU are progressing. I think it is more a case of wanting
him to stick to the script. This is why he went back to the slides each time, so that he didn't accidentally 'stray'.

You will recall the speculation that was generated after Leslie through out the line ... "and we are also monetizing some of our
other products as well" ... so IMU management would be keen to manage the information flow.

Dr Glover did reiterate that IMU is looking at several (not one) expansion cohorts in the MAST trial. He states ... "we expect
to expand our cohorts into specific tumor types, including cholangiocarcinoma (bile duct cancer)". We may learn of the new
expansion soon after the next data cut.

This appears to be the process that they will also follow through with onCARlytics ... identify a 'rarer' cancer, where our
treatment is very efficacious, and launch the next expansion in that direction. Very sensible, and likely to speed us towards
confirmation trials far more quickly.

All opinion only.

Expand

Some scientists are good behind the microscope and some are good behind the microphone, but rarely one is good at both. ....

IMU Price at posting: 10.5¢ Sentiment: Buy Disclosure: Held
10 Upvote

0 Great analysis

Reply

Top Stories

SRL

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

OCC

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

SPR

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

MSB

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

PL3

Patagonia looks to raise $2.15M for South American exploration and development

There are more pages in this discussion • 1,936 more messages in this thread...

First 12662 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 5.1¢		Change 0.001(2.00%)		Mkt cap ! $374.8M

Open	High	Low	Value	Volume
5.0¢	5.2¢	4.9¢	$541.6K	10.76M

Buyers (Bids)

No.	Vol.	Price($)
8	818590	5.0¢

Sellers (Offers)

Price($)	Vol.	No.
5.1¢	249636	1

View Market Depth

No.	Vol.	Price($)
7	618590	0.050
40	5683742	0.049
27	1923707	0.048
12	1004292	0.047
17	975390	0.046

Price($)	Vol.	No.
0.051	249636	1
0.052	3008410	14
0.053	1998507	7
0.054	1087199	6
0.055	1401256	13

Last trade - 16.10pm 09/07/2024 (20 minute delay)

IMU (ASX) Chart

Media Thread, page-12662

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Media Thread, page-12662

Top Stories

Scandium a priority metal for Sunrise as it plans feasibility update at Syerston

Orthocell shares jump on record revenues from sales of collagen bone repair devices globally

Spartan sniffs 126g/t gold ahead of resource upgrades at WA's Dalgaranga

Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%

Patagonia looks to raise $2.15M for South American exploration and development

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News